Lucira Health, Inc.
LHDXDelisted Apr 12, 2023- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652724
Lucira Health, Inc. was delisted on Apr 12, 2023; its insiders filed their last Form 4 on Mar 13, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $1.04M in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Lucira Health, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 38 | 28 | −10 |
| Shares | 22.7M | 22.9M | +193.7K (+0.9%) |
| Value | $42.2M | $24.2M | −$17.9M (−42.5%) |
New holders (5)
Institutions that held Lucira Health, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 618,643 | $656.0K | 0.00% |
| AlphaCentric Advisors LLC | 320,200 | $339.0K | 0.35% |
| Tower Research Capital LLC (TRC) | 3,550 | $4.00K | 0.00% |
| JPMorgan Chase & Co | 8 | $0 | 0.00% |
| Bogart Wealth, LLC | 200 | $0 | 0.00% |
Sold out (15)
Institutions that held Lucira Health, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Pura Vida Investments, LLC | 690,663 | $1.28M |
| Choice Wealth Advisors, LLC | 97,518 | $181.0K |
| CastleKnight Management LP | 66,700 | $124.0K |
| Renaissance Technologies LLC | 41,800 | $78.0K |
| Millennium Management LLC | 29,436 | $55.0K |
| Susquehanna International Group, LLP | 28,521 | $53.0K |
| Gsa Capital Partners LLP | 26,516 | $49.0K |
| Price T Rowe Associates Inc | 17,400 | $32.0K |
| D. E. Shaw & Co., Inc. | 13,866 | $26.0K |
| ETF Managers Group, LLC | 12,596 | $22.0K |
| Commonwealth Equity Services, LLC | 11,000 | $20.0K |
| Barclays PLC | 4,016 | $7.00K |
| Cutler Group LP | 3,515 | $6.00K |
| Captrust Financial Advisors | 319 | $1.00K |
| Bank of America Corp | 45 | $0 |